These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15157043)

  • 41. Prediction of the responsiveness to treatment with erythropoiesis-stimulating factors: a prospective clinical study in patients with solid tumors.
    Steinmetz T; Hellmich M; Neise M; Aldaud A; Lerchenmüller C; Tsamaloukas A; Fandel F; Weiligmann C; Totzke U; Schmitz S
    Oncologist; 2007 Jun; 12(6):748-55. PubMed ID: 17602064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?
    Brown P; Clark MM; Atherton P; Huschka M; Sloan JA; Gamble G; Girardi J; Frost MH; Piderman K; Rummans TA
    Am J Clin Oncol; 2006 Feb; 29(1):52-8. PubMed ID: 16462503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin.
    Wacker P; Ozsahin H; Stelling MJ; Humbert J
    Pediatr Hematol Oncol; 2001 Jun; 18(4):279-82. PubMed ID: 11400653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
    Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. rHuEPO and improved treatment outcomes: potential modes of action.
    Blackwell K; Gascón P; Sigounas G; Jolliffe L
    Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anemia in multiple myeloma.
    Ludwig H; Pohl G; Osterborg A
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initiation of epoetin-alpha therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy: an open-label, multicenter study with randomized and nonrandomized treatment arms.
    Glaspy JA; Charu V; Luo D; Moyo V; Kamin M; Wilhelm FE
    Cancer; 2009 Mar; 115(5):1121-31. PubMed ID: 19170225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial.
    Vijayakumar S; Roach M; Wara W; Chan SK; Ewing C; Rubin S; Sutton H; Halpern H; Awan A; Houghton A
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):721-9. PubMed ID: 8331011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythropoietin increases hemoglobin in cancer patients during radiation therapy.
    Lavey RS; Dempsey WH
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1147-52. PubMed ID: 8262840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Human recombinant erythropoietin in the treatment of the severe anemia following labor (a preliminary report)].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(4):13-5. PubMed ID: 10726343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: preliminary results.
    James RD; Wilkinson PM; Belli F; Welch R; Cowan R
    Acta Haematol; 1992; 87 Suppl 1():12-5. PubMed ID: 1574960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors.
    León P; Jiménez M; Barona P; Sierrasesúmaga L
    Med Pediatr Oncol; 1998 Feb; 30(2):110-6. PubMed ID: 9403020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-globin mRNA increases rapidly during erythropoietin treatment.
    Hagberg A; Barbany G; Landegren U; Birgegård G
    Scand J Clin Lab Invest; 2003; 63(3):239-45. PubMed ID: 12817911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness?
    Bellazzi R; Siviero C; Bellazzi R
    Haematologica; 1994; 79(2):154-64. PubMed ID: 8063263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.